Genetics, baseline metabolic health, sleep, medications youre already taking, and how much protein and resistance training youre getting all move the needle
I use the Mifflin-St
An ideal 3-month InBody result on semaglutide with appropriate support shows: body fat mass reduced by 24 kg, skeletal muscle mass stable or minimally changed (within 0.3 kg of baseline), visceral fat level reduced by at least 1 level, BMR within 75100 kcal of baseline, and phase angle stable or improved
[309] [310] In other nations, such as Brazil (class A3), [311] Canada (schedule I drug), [312] the Netherlands (List I drug), [313] the United States (schedule II drug), [7] Australia (schedule 8), [314] Thailand (category 1 narcotic), [315] and United Kingdom (class B drug), [316] amphetamine is in a restrictive national drug schedule that allows for its use as a medical treatment